LEVOICE-AM Tablet is a dual-action respiratory care formulation combining Acebrophylline (Sustained Release) and Montelukast, developed to provide long-lasting relief in patients suffering from asthma, chronic bronchitis, COPD, and other allergic respiratory conditions. Acebrophylline, a mucolytic and bronchodilator, helps reduce airway inflammation, enhances mucus clearance, and promotes bronchodilation for easier breathing. Montelukast, a leukotriene receptor antagonist, works by blocking allergic and inflammatory responses triggered by environmental allergens. Together, this combination in LEVOICE-AM offers comprehensive respiratory support by addressing both bronchial obstruction and allergic inflammation. With its sustained-release formulation, LEVOICE-AM Tablet ensures 24-hour symptom control, better compliance, and improved quality of life for patients with chronic respiratory disorders.
Price: